key: cord-0718685-d48gxvw0
authors: Cardenas, Nicky C
title: ‘US–European centrality’: strategic policy for global COVID-19 response and health security
date: 2021-06-11
journal: J Public Health (Oxf)
DOI: 10.1093/pubmed/fdab207
sha: ebee2554f5e421d2727b7f2a0955b7730d477108
doc_id: 718685
cord_uid: d48gxvw0

nan

In consultation with the World Health Organization (WHO) SARS-CoV-2 Virus Evolution Working Group, WHO sounded a global alarm due to the newly designated Indian 'variant of concern' within the lineage B.1.617. 1 WHO determined that, 'B.1.617 sub-lineages appear to have higher rates of transmission, including observed rapid increases in prevalence in multiple countries (moderate evidence available for B.1.617.1 and B.1.617.2)'. This new evidence continuously threatens the whole world as each nation currently grapples in combating COVID-19.

With the continuous surge of COVID-19 and new variants of concerns, this paper argues that US-European centrality is urgently needed toward cohesive and comprehensive transatlantic 'One Health' approach in addressing global COVID-19 response and health security. Thus, this correspondence critically urges US-European strategic cooperation to work closely toward a more concrete, collective, comprehensive, multifaceted and multilateral global COVID-19 'One Health' approach and develop an enhanced transatlantic post-pandemic recovery to demonstrate transformational leadership, responsibility and solidarity around the world.

In my recent correspondence in this Journal of Public Health (Oxford), I proposed a viable 'US-European-ASEAN' strategic plan on COVID-19, 2 anchored on critical reflections of Webster and Neal (2021) 3 toward transformational leadership during COVID-19. I emphasized the dire need for strengthening transatlantic multilateral diplomacy to help ASEAN member states toward an enhanced post-pandemic recovery plan. However, this current paper addresses gaps on global COVID-19 multilateral response from US-European superpowers to end pandemic, reduce transmission of new variant of concerns, provide health security and recover economically together.

Recently, G7 Foreign and Development Ministers' Meeting showed replenishing of bilateral and multilateral relations and building back a transatlantic cooperation to combat COVID-19, 4 but there is a necessity for stronger public support and e cient delegation from US-European constituents to demonstrate centralization, strategic policy-making, decision-making and multilateral e orts for global COVID-19 response. With this, transatlantic cooperation will exhibit centrality on e cient implementation of joint vaccine procurement, rollout and fill in the gaps on vaccine production and manufacturing.

In a recent article, the authors succinctly pointed out the need for 'e ective international joint procurement that requires su cient scope, capacity to organize solidarity with countries most in need and delegation in the decisionmaking'. 5 Results of their study reiterated the important role of European Union (EU) joint procurement of medical countermeasures to large-scale disease outbreaks with considerable public support on EU centrality. This implies call for stronger public support on US centrality during COVID-19. However, there is a dire need for joint US-European superpowers to develop coordinated strategic transatlantic pandemic policy against COVID-19 and new variants surge.

Evidence revealed that US strategic multilateral approach centered on putting an end to pandemic, reduce variants and demonstrate leadership through comprehensive vaccine strategy. 6 Biden-Harris administration announced that the USA will provide 80 million vaccine doses to help countries around the world to combat COVID-19 and the USA ensured to work with G7, EU, COVAX, G20 and other partners for equitable access to vaccines, spur production and manufacturing for vaccines and raw materials to reach herd immunity. 7 In similar way, European strategic policy revealed a multilateral approach for comprehensive global COVID-19 response for equitable access to COVID-19 vaccines with the aim to donate at least 100 million doses by the end of 2021 and to help in developing local manufacturing capacity 8 in accordance to Rome Declaration of the Global Summit. 9 Evidence also showed that European Commission addressed the dire need for global comprehensive pandemic response to countries greatly hard hit by COVID-19 and EU o ered assistance amounting to 'e2.47 billion contribution to the COVAX initiative and with over e40.5 million doses of vaccines that have been delivered to >100 countries worldwide'. 10 Thus, US-European superpowers are demonstrating remarkable leadership, responsibility and solidarity. However, development of comprehensive transatlantic 'One Health' approach on vaccine strategy is still direly needed to reach herd immunity around the world.

The author declares no conflict of interest in this paper.

US-European and ASEAN strategic plan on COVID-19: a proposed multilateral diplomacy

Covid reflections-let us talk of politicians and professors

G7. G7 Foreign and Development Ministers' Meeting: Communiqué. 3-5

Public support for European cooperation in the procurement, stockpiling and distribution of medicines

State Department Coordinator for Global COVID-19 Response and Health Security

Fact Sheet: Biden-Harris Administration is providing at least 80 million COVID-19 vaccines for global use, commits to leading a multilateral e ort toward ending the pandemic

European Council conclusions on COVID-19

Rome Declaration

Coronavirus: EU channels critical support to India via EU Civil Protection Mechanism